Daratumumab/hyaluronidase Interactions
There are 270 drugs known to interact with daratumumab/hyaluronidase, along with 2 disease interactions. Of the total drug interactions, 50 are major, 138 are moderate, and 82 are minor.
- View all 270 medications that may interact with daratumumab/hyaluronidase
- View daratumumab/hyaluronidase disease interactions (2)
Most frequently checked interactions
View interaction reports for daratumumab / hyaluronidase and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- Aranesp (darbepoetin alfa)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- B-12 (cyanocobalamin)
- Banophen (diphenhydramine)
- Belbuca (buprenorphine)
- Belsomra (suvorexant)
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- Breo Ellipta (fluticasone / vilanterol)
- Calcium 600 D (calcium / vitamin d)
- Coenzyme Q10 (ubiquinone)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Lasix (furosemide)
- Metoprolol Succinate ER (metoprolol)
- Norco (acetaminophen / hydrocodone)
- Plavix (clopidogrel)
- Pomalyst (pomalidomide)
- Revlimid (lenalidomide)
- Senokot (senna)
- Tylenol (acetaminophen)
- Velcade (bortezomib)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xgeva (denosumab)
- Zometa (zoledronic acid)
Daratumumab/hyaluronidase disease interactions
There are 2 disease interactions with daratumumab / hyaluronidase which include:
Report options
QR code containing a link to this page
More about daratumumab / hyaluronidase
- daratumumab/hyaluronidase consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD38 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
